Cargando…

Rethinking Oncologic Treatment Strategies with Interleukin-2

High-dose recombinant human IL-2 (rhIL-2, aldesleukin) emerged as an important treatment option for selected patients with metastatic melanoma and metastatic renal cell carcinoma, producing durable and long-lasting antitumor responses in a small fraction of patients and heralding the potential of ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, Brian, Takebe, Naoko, Andrews, Omozusi, Makena, Monish Ram, Chen, Alice P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177415/ https://www.ncbi.nlm.nih.gov/pubmed/37174716 http://dx.doi.org/10.3390/cells12091316

Ejemplares similares

Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells
por: Makena, Monish Ram, et al.
Publicado: (2021)

Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors
por: Yavvari, Siddhartha, et al.
Publicado: (2019)

Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer
por: Pramanik, Kartick C., et al.
Publicado: (2018)

Rethinking interleukin-6 blockade for treatment of COVID-19
por: Scherger, S., et al.
Publicado: (2020)

Rethinking glioma treatment strategy
por: Ozawa, Tatsuya, et al.
Publicado: (2014)

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
por: Gatla, Himavanth Reddy, et al.
Publicado: (2019)

Rethinking Strategy
por: Tighe, Steve
Publicado: (2019)

Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11
por: Jo, Ukhyun, et al.
Publicado: (2021)

Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
por: Ram Makena, Monish, et al.
Publicado: (2019)

Rethinking disability: The need to rethink representation
por: Procter, Jenna-Lee
Publicado: (2018)

A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy
por: Fujiwara, Yu, et al.
Publicado: (2020)

Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
por: Bizzarri, Mariano, et al.
Publicado: (2021)

Rethinking Addiction
por: Ewald, D. Rose, et al.
Publicado: (2019)

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
por: Meyerowitz, Eric A., et al.
Publicado: (2020)

Secretory pathway Ca(2+)-ATPase SPCA2 regulates mitochondrial respiration and DNA damage response through store-independent calcium entry
por: Makena, Monish Ram, et al.
Publicado: (2022)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Rethinking fatigue in Gaucher disease
por: Zion, Y. Chen, et al.
Publicado: (2016)

Rethinking Heart Failure
por: Fürstenwerth, Hauke
Publicado: (2012)

Rethinking Resistant Hypertension
por: Bourque, Gabrielle, et al.
Publicado: (2022)

Rethinking the tools in the toolbox
por: George Hornby, T.
Publicado: (2022)

RNAi-Mediated Gene silencing in Zebrafish Triggered by Convergent Transcription
por: Andrews, Omozusi E., et al.
Publicado: (2014)

Malaria Elimination in Africa: Rethinking Strategies for Plasmodium vivax and Lessons from Botswana
por: Quaye, Isaac K., et al.
Publicado: (2023)

Necessity of Rethinking about the Preventive Strategies of Addiction
por: Riasaty, Ali
Publicado: (2017)

Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
por: Lim, Bora, et al.
Publicado: (2019)

Rethinking strategies for blood transfusion in hip fracture patients
por: D’Amore, Taylor, et al.
Publicado: (2020)

Modern treatment strategies in pediatric oncology and hematology
por: Adamczewska-Wawrzynowicz, Katarzyna, et al.
Publicado: (2023)

Rethinking Biosynthesis of Aclacinomycin A
por: Xu, Ziling, et al.
Publicado: (2023)

Rethinking Colour Constancy
por: Logvinenko, Alexander D., et al.
Publicado: (2015)

Eliminating Spiked Bovine Spongiform Encephalopathy Agent Activity from Heparin
por: Bett, Cyrus, et al.
Publicado: (2020)

Mortality in patients with cirrhosis admitted to the ICU: time to rethink strategies?
por: Vaz, A, et al.
Publicado: (2015)

Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case
por: Hoda, Mir Alireza, et al.
Publicado: (2018)

Rethinking the Significance of Reovirus in Water and Wastewater
por: Betancourt, Walter Q., et al.
Publicado: (2016)

Erratum: Rethinking disability: The need to rethink representation
por: Procter, Jenna-Lee
Publicado: (2019)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

Rethinking Bone Disease in Kidney Disease
por: Damasiewicz, Matthew J, et al.
Publicado: (2018)

Rethinking integrated service delivery for malaria
por: Ansah, Evelyn K., et al.
Publicado: (2022)

Rethinking communications for governance of malaria programs
por: Opigo, Jimmy, et al.
Publicado: (2023)

Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models
por: Foldi, Claire J., et al.
Publicado: (2020)

Drug induced interstitial lung disease in oncology phase I trials
por: Yonemori, Kan, et al.
Publicado: (2016)

Antipsychotic Maintenance Treatment: Time to Rethink?
por: Moncrieff, Joanna
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4hf44dq7vudpp0kbtqe9saeqor